Skip to content
★ Sign in to follow
JW
Total declarations
22
Company
1
▲ Purchases (1 ops.)
€51k
▼ Sales (5 ops.)
€74k

Latest filing published 28 Feb 2019 for PERRIGO Co plc, €17k.

Filing timeline

BuySale
John Wesolowski

Insider track record

Disclosed buys
1
Disclosed sells
5
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 19 Dec 2017 · 3247 days ago · €51k
    -39.5%
    Entry US$86.53 · Close at T+365 US$52.36

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

John Wesolowski: trading record in brief

John Wesolowski is a declared insider of PERRIGO Co plc, with filings sourced from SEC (Form 4). Between 15 December 2016 and 26 February 2019, the trades on record add up to 22 filings.

The open-market side counts 1 purchase for €51k alongside 5 sales for €74k. Netting one side against the other leaves €23k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 10 share grants and 6 option exercises.

The newest entry dates from 28 February 2019: a share grant of €17k, in PERRIGO Co plc. The last insider purchase was made public on 19 December 2017, 3,247 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to John Wesolowski

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations22 total
  • ◆
    EVP, President RxExecutivesPERRIGO Co plc
    19,751 USD24SEC
    409 shares@ US$48.2922.2% of flowOrdinary SharesSEC:0001585364-19-000018:0
  • ◆
    EVP, President RxExecutivesPERRIGO Co plc
    6,712 USD23SEC
    139 shares@ US$48.297.5% of flowOrdinary SharesSEC:0001585364-19-000018:1
  • ◇
    EVP, President RxExecutivesPERRIGO Co plc
    13,618 USD24SEC
    282 shares@ US$48.2915.3% of flowOrdinary SharesSEC:0001585364-19-000018:2
  • ◆
    EVP, President RxExecutivesPERRIGO Co plc
    4,636 USD23SEC
    96 shares@ US$48.295.2% of flowOrdinary SharesSEC:0001585364-19-000018:3
  • ◇
    EVP, President RxExecutivesPERRIGO Co plc
    35,070 USD25SEC
    481 shares@ US$72.919.4% of flowOrdinary SharesSEC:0001585364-18-000053:0
  • ◆
    EVP, President RxExecutivesPERRIGO Co plc
    10,062 USD24SEC
    138 shares@ US$72.912.7% of flowOrdinary SharesSEC:0001585364-18-000053:1
  • ◇
    EVP, President RxExecutivesPERRIGO Co plc
    82,196 USD26SEC
    1,033 shares@ US$79.5717.4% of flowOrdinary SharesSEC:0001689938-18-000002:0
  • ◆
    EVP, President RxExecutivesPERRIGO Co plc
    26,338 USD25SEC
    331 shares@ US$79.575.6% of flowOrdinary SharesSEC:0001689938-18-000002:1
  • ◇
    EVP, President RxExecutivesPERRIGO Co plc
    28,026 USD25SEC
    324 shares@ US$86.506.1% of flowOrdinary SharesSEC:0001689938-17-000004:0
  • ◆
    EVP, President RxExecutivesPERRIGO Co plc
    8,910 USD24SEC
    103 shares@ US$86.501.9% of flowOrdinary SharesSEC:0001689938-17-000004:1
  • ▲
    EVP, President RxExecutivesPERRIGO Co plc
    60,060 USD23SEC
    700 shares@ US$85.8013.1% of flowOrdinary SharesSEC:0001689938-17-000007:0
    Canonical exit: 14 Mar 2018 (T+90)
  • ▼
    EVP, President RxExecutivesPERRIGO Co plc
    16,621 USD40SEC
    201.73 shares@ US$82.393.6% of flowOrdinary SharesSEC:0001689938-17-000006:0
  • ▼
    EVP, President RxExecutivesPERRIGO Co plc
    37,391 USD35SEC
    450 shares@ US$83.098.2% of flowOrdinary SharesSEC:0001585364-17-000162:0
  • ▼
    EVP, President RxExecutivesPERRIGO Co plc
    19,109 USD34SEC
    220 shares@ US$86.864.1% of flowOrdinary SharesSEC:0001585364-17-000161:0
  • ▼
    EVP, President RxExecutivesPERRIGO Co plc
    5,960 USD34SEC
    68 shares@ US$87.641.3% of flowOrdinary SharesSEC:0001585364-17-000161:1
  • ▼
    EVP, President RxExecutivesPERRIGO Co plc
    8,766 USD34SEC
    100 shares@ US$87.661.9% of flowOrdinary SharesSEC:0001585364-17-000161:2
  • ◇
    EVP, President RxExecutivesPERRIGO Co plc
    10,396 USD22SEC
    134 shares@ US$77.582.3% of flowOrdinary SharesSEC:0001585364-17-000138:0
  • ◆
    EVP, President RxExecutivesPERRIGO Co plc
    3,336 USD22SEC
    43 shares@ US$77.580.7% of flowOrdinary SharesSEC:0001585364-17-000138:1
  • ◆
    EVP, President RxExecutivesPERRIGO Co plc
    17,611 USD22SEC
    227 shares@ US$77.583.8% of flowOrdinary SharesSEC:0001585364-17-000138:2
  • ◆
    EVP, President RxExecutivesPERRIGO Co plc
    5,586 USD22SEC
    72 shares@ US$77.581.2% of flowOrdinary SharesSEC:0001585364-17-000138:3
  • ◇
    EVP, President RxExecutivesPERRIGO Co plc
    26,848 USD23SEC
    325 shares@ US$82.616.6% of flowOrdinary SharesSEC:0001585364-16-000446:0
  • ◆
    EVP, President RxExecutivesPERRIGO Co plc
    8,509 USD22SEC
    103 shares@ US$82.612.1% of flowOrdinary SharesSEC:0001585364-16-000446:1

22 of 22 declarations